Li, Y., Cen, H., Li, Z., Zhang, Y., Li, Z., Xie, Y., Liu, H., Li, J., Zhou, K., Fang, M., Li, X., Jin, Z., Tu, S., Liu, Y., Ma, D., Mao, W., Xiao, Z., Zheng, H., Song, Y. (2025). CD79b-targeted antibody-drug conjugate (ADC) SHR-A1912 in combination with rituximab, gemcitabine, and oxaliplatin (R-GemOx) in relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL): Data from a phase 1b/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7013